Hatch/Waxman Reform Bill Needed Despite FDA Rule – McCain, Schumer
This article was originally published in The Tan Sheet
Executive Summary
Legislation to reform the generic drug approval process will still be needed following issuance of FDA's final rule, Sens. John McCain (R-Ariz.) and Charles Schumer (D-N.Y.) said
You may also be interested in...
Senate Health Committee Plans To Codify FDA Generic Drug Proposal
The Senate Health & Education Committee plans to codify FDA's Hatch/Waxman reform proposal after the final rule is issued
Senate Health Committee Plans To Codify FDA Generic Drug Proposal
The Senate Health & Education Committee plans to codify FDA's Hatch/Waxman reform proposal after the final rule is issued
Senate Health Committee Plans To Codify FDA Generic Drug Proposal
The Senate Health & Education Committee plans to codify FDA's Hatch/Waxman reform proposal after the final rule is issued